372 related articles for article (PubMed ID: 17760815)
41. Effect of YM598, a selective endothelin ETA receptor antagonist, on endothelin-1-induced bone formation.
Someya A; Yuyama H; Fujimori A; Ukai M; Fukushima S; Sasamata M
Eur J Pharmacol; 2006 Aug; 543(1-3):14-20. PubMed ID: 16843458
[TBL] [Abstract][Full Text] [Related]
42. Increased expression of the peroxisome proliferator-activated receptor gamma in the immune system of weaned pigs after Escherichia coli lipopolysaccharide injection.
Liu Y; Lu J; Shi J; Hou Y; Zhu H; Zhao S; Liu H; Ding B; Yin Y; Yi G
Vet Immunol Immunopathol; 2008 Jul; 124(1-2):82-92. PubMed ID: 18394717
[TBL] [Abstract][Full Text] [Related]
43. Cyclooxygenase-2 inhibition selectively attenuates bone morphogenetic protein-6 synthesis and bone formation during guided tissue regeneration in a rat model.
Damrongsri D; Geva S; Salvi GE; Williams RC; Limwongse V; Offenbacher S
Clin Oral Implants Res; 2006 Feb; 17(1):38-47. PubMed ID: 16441783
[TBL] [Abstract][Full Text] [Related]
44. Neuroprotective effects of prostaglandin A(1) in rat models of permanent focal cerebral ischemia are associated with nuclear factor-kappaB inhibition and peroxisome proliferator-activated receptor-gamma up-regulation.
Zhang HL; Gu ZL; Savitz SI; Han F; Fukunaga K; Qin ZH
J Neurosci Res; 2008 Apr; 86(5):1132-41. PubMed ID: 18074385
[TBL] [Abstract][Full Text] [Related]
45. Heparin inhibits BMP-2 osteogenic bioactivity by binding to both BMP-2 and BMP receptor.
Kanzaki S; Takahashi T; Kanno T; Ariyoshi W; Shinmyouzu K; Tujisawa T; Nishihara T
J Cell Physiol; 2008 Sep; 216(3):844-50. PubMed ID: 18449905
[TBL] [Abstract][Full Text] [Related]
46. Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates acrolein-induced airway mucus hypersecretion in rats.
Liu DS; Liu WJ; Chen L; Ou XM; Wang T; Feng YL; Zhang SF; Xu D; Chen YJ; Wen FQ
Toxicology; 2009 Jun; 260(1-3):112-9. PubMed ID: 19464576
[TBL] [Abstract][Full Text] [Related]
47. A local bone anabolic effect of rhFGF2-impregnated gelatin hydrogel by promoting cell proliferation and coordinating osteoblastic differentiation.
Kodama N; Nagata M; Tabata Y; Ozeki M; Ninomiya T; Takagi R
Bone; 2009 Apr; 44(4):699-707. PubMed ID: 19166987
[TBL] [Abstract][Full Text] [Related]
48. Up-regulation of peroxisome proliferator-activated receptor gamma in perennial allergic rhinitis.
Kang HJ; Cinn YG; Hwang SJ; Won Chae S; Woo JS; Lee SH; Lee HM
Arch Otolaryngol Head Neck Surg; 2006 Nov; 132(11):1196-200. PubMed ID: 17116814
[TBL] [Abstract][Full Text] [Related]
49. Bacillus Calmette-Guérin induces the expression of peroxisome proliferator-activated receptor gamma in bladder cancer cells.
Lodillinsky C; Umerez MS; Jasnis MA; Casabé A; Sandes E; Eiján AM
Int J Mol Med; 2006 Feb; 17(2):269-73. PubMed ID: 16391825
[TBL] [Abstract][Full Text] [Related]
50. Pulsed electromagnetic fields simultaneously induce osteogenesis and upregulate transcription of bone morphogenetic proteins 2 and 4 in rat osteoblasts in vitro.
Bodamyali T; Bhatt B; Hughes FJ; Winrow VR; Kanczler JM; Simon B; Abbott J; Blake DR; Stevens CR
Biochem Biophys Res Commun; 1998 Sep; 250(2):458-61. PubMed ID: 9753652
[TBL] [Abstract][Full Text] [Related]
51. Activation of peroxisome proliferator-activated receptor-gamma (PPAR-gamma) by atorvastatin is mediated by 15-deoxy-delta-12,14-PGJ2.
Ye Y; Nishi SP; Manickavasagam S; Lin Y; Huang MH; Perez-Polo JR; Uretsky BF; Birnbaum Y
Prostaglandins Other Lipid Mediat; 2007 Aug; 84(1-2):43-53. PubMed ID: 17643887
[TBL] [Abstract][Full Text] [Related]
52. Circulating bone marrow-derived osteoblast progenitor cells are recruited to the bone-forming site by the CXCR4/stromal cell-derived factor-1 pathway.
Otsuru S; Tamai K; Yamazaki T; Yoshikawa H; Kaneda Y
Stem Cells; 2008 Jan; 26(1):223-34. PubMed ID: 17932420
[TBL] [Abstract][Full Text] [Related]
53. Bone morphogenetic protein 2 induces cyclo-oxygenase 2 in osteoblasts via a Cbfa1 binding site: role in effects of bone morphogenetic protein 2 in vitro and in vivo. 2002.
Chikazu D; Li X; Kawaguchi H; Sakuma Y; Voznesensky OS; Adams DJ; Xu M; Hoshi K; Katavic V; Herschman HR; Raisz LG; Pilbeam CC
J Bone Miner Res; 2005 Oct; 20(10):1888-98. PubMed ID: 16355502
[No Abstract] [Full Text] [Related]
54. [Expression of nerve growth factor and its receptor during osteoinduction of recombined human bone morphogenetic protein 2].
Xia S; Dai K; Tang T
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Apr; 20(4):454-8. PubMed ID: 16683456
[TBL] [Abstract][Full Text] [Related]
55. RANKL directly induces bone morphogenetic protein-2 expression in RANK-expressing POS-1 osteosarcoma cells.
Wittrant Y; Lamoureux F; Mori K; Riet A; Kamijo A; Heymann D; Redini F
Int J Oncol; 2006 Jan; 28(1):261-9. PubMed ID: 16328004
[TBL] [Abstract][Full Text] [Related]
56. Peroxisome proliferator-activated receptor gamma: a novel target for cancer therapeutics?
Han S; Roman J
Anticancer Drugs; 2007 Mar; 18(3):237-44. PubMed ID: 17264754
[TBL] [Abstract][Full Text] [Related]
57. beta-Carotene induces apoptosis and up-regulates peroxisome proliferator-activated receptor gamma expression and reactive oxygen species production in MCF-7 cancer cells.
Cui Y; Lu Z; Bai L; Shi Z; Zhao WE; Zhao B
Eur J Cancer; 2007 Nov; 43(17):2590-601. PubMed ID: 17911009
[TBL] [Abstract][Full Text] [Related]
58. Bone formation zones in heterotopic ossifications: histologic findings and increased expression of bone morphogenetic protein 2 and transforming growth factors beta2 and beta3.
Toom A; Arend A; Gunnarsson D; Ulfsparre R; Suutre S; Haviko T; Selstam G
Calcif Tissue Int; 2007 Apr; 80(4):259-67. PubMed ID: 17401695
[TBL] [Abstract][Full Text] [Related]
59. Effect of dexamethasone on peroxisome proliferator activated receptor-gamma mRNA expression in 3T3-L1 adipocytes with the human recombinant adiponectin.
She QM; Zhao J; Wang XL; Zhou CM; Shi XZ
Chin Med J (Engl); 2007 Jan; 120(2):155-8. PubMed ID: 17335662
[TBL] [Abstract][Full Text] [Related]
60. Potential for peroxisome proliferator-activated receptor-gamma agonists in progression: beyond metabolism.
Fogo AB
Curr Opin Nephrol Hypertens; 2008 May; 17(3):282-5. PubMed ID: 18408479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
